Interferon Beta-1a injectable bulk supplier for pharma manufacturers

Interferon Beta-1A Injectable Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 30 mcg, 22 mcg or 44 mcg,125 mcg, 125 mcg, 150 mcg,175 mcg

Reference Brands: Avonex, Rebif, Plegridy(US &EU)

Interferon Beta-1a reduces inflammation and modulates immune responses in multiple sclerosis by inhibiting pro-inflammatory cytokines and immune cell activity. It decreases relapse rates, slows disease progression, and reduces lesion development. Benefits include improved neurological function, symptom control, and enhanced quality of life for MS patients.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Interferon Beta-1a, marketed as Avonex, Rebif, and Plegridy, is approved in the US by the FDA and in the EU via EMA for multiple sclerosis treatment. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety data, manufacturing quality, and pharmacovigilance plans. In the US, FDA review involves detailed analysis of clinical trial results and manufacturing processes, while the EU ensures compliance with regional standards.

Interferon Beta-1A Injectable — third party manufacturing & bulk supply

Interferon Beta-1A Injectable is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Interferon Beta-1A Injectable is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Interferon Beta-1A Injectable listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Interferon Beta-1A Injectable →

Back to Listing

Frequently Asked Questions

Interferon beta-1a is used for the treatment of relapsing forms of multiple sclerosis (MS). It helps reduce the frequency of disease relapses and may slow the progression of physical disability. The medicine works by regulating immune system activity and reducing inflammation that can damage nerve cells in the central nervous system.

Interferon beta-1a is a recombinant protein produced using advanced biotechnology. It is manufactured through genetic engineering in mammalian cells to create a protein that is very similar to naturally occurring human interferon beta.

Common trade names of Interferon beta-1a include Avonex and Rebif.

Interferon beta-1a products are manufactured by companies such as Biogen and Merck KGaA, depending on the brand and region.

The generic name is Interferon beta-1a.

Well-known brand names include Avonex and Rebif.

Interferon beta-1a is manufactured in regulated biopharmaceutical production facilities in countries such as the United States and several European nations under strict quality and safety standards.